Related Experiment Video
Updated: Jan 26, 2026
Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
Microglial NLRP3 inflammasome activation mediates IL-1β release and contributes to central sensitization in a
1Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, 1st You Yi Road, Yu Zhong District, Chongqing, 400016, People's Republic of China.
Background:
Central sensitization is an important mechanism of chronic migraine (CM) and is related to the inflammatory response of microglia. The NOD-like receptor protein 3 (NLRP3) inflammasome may regulate the inflammatory process of microglia in several neurological diseases, but its role in CM is largely unknown. Therefore, the aim of this study was to identify the precise role of microglial NLRP3 in CM.
Methods:
An experimental CM mouse model was established by repeated intraperitoneal (i.p) injection with nitroglycerin (NTG). We evaluated the expression levels of NLRP3 and its downstream interleukin (IL)-1β protein in the trigeminal nucleus caudalis (TNC; which is a central area relevant to migraine pain) at different time points. To further examine the effects of the NLRP3 inflammasome pathway on central sensitization of CM, we examined MCC950, an NLRP3 inflammasome-specific inhibitor, and IL-1ra, an IL-1β antagonist, whether altered NTG-induced mechanical hyperalgesia of the periorbital area and hind paw. The effect of MCC950 and IL-1ra on c-Fos, phosphorylated extracellular signal-regulated kinase (p-ERK) and calcitonin gene-related peptide (CGRP) expression in the TNC were also analyzed. The cell localization of NLRP3 and IL-1β in the TNC was evaluated by immunofluorescence staining.
Results:
Repeated NTG administration induced acute and chronic mechanical hyperalgesia and increased expression of NLRP3 and IL-1β. Blockade of NLRP3 or IL-1β reduced NTG-induced hyperalgesia, and this effect was accompanied by a significant inhibition of the NTG-induced increase in p-ERK, c-Fos and CGRP levels in the TNC. Immunofluorescence staining revealed that NLRP3 and IL-1β were mainly expressed in microglia in the TNC, and the IL-1β receptor, IL-1R, was mainly expressed in neurons in the TNC.
Conclusions:
These results indicate that NLRP3 activation in the TNC participates in the microglial-neuronal signal by mediating the inflammatory response. This process contributes to the central sensitization observed in CM.
Insights
Microglial NLRP3 inflammasome activation contributes to chronic migraine by mediating neuroinflammation and central sensitization. Inhibiting NLRP3 or IL-1β reduces migraine-associated pain and neuronal signaling.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Central sensitization is a key mechanism in chronic migraine (CM), linked to microglial inflammatory responses.
- The role of the NOD-like receptor protein 3 (NLRP3) inflammasome in CM pathogenesis is not well understood.
- This study investigates the specific role of microglial NLRP3 in CM.
Purpose of the Study:
- To elucidate the role of microglial NLRP3 inflammasome in the development of chronic migraine.
- To determine if NLRP3 activation in the trigeminal nucleus caudalis (TNC) contributes to central sensitization in CM.
- To evaluate the therapeutic potential of targeting the NLRP3 inflammasome pathway in CM.
Main Methods:
- An experimental CM mouse model was induced using repeated nitroglycerin (NTG) injections.
- Expression levels of NLRP3 and IL-1β in the TNC were measured.
- The effects of the NLRP3 inhibitor MCC950 and IL-1β antagonist IL-1ra on NTG-induced hyperalgesia and neuronal markers (c-Fos, p-ERK, CGRP) in the TNC were assessed.
- Immunofluorescence staining identified NLRP3 and IL-1β localization in microglia and IL-1R in neurons within the TNC.
Main Results:
- Repeated NTG administration led to mechanical hyperalgesia and increased NLRP3 and IL-1β expression in the TNC.
- Inhibition of NLRP3 or IL-1β significantly reduced NTG-induced hyperalgesia.
- Treatment with MCC950 or IL-1ra attenuated the NTG-induced increase in p-ERK, c-Fos, and CGRP in the TNC.
- NLRP3 and IL-1β were primarily located in TNC microglia, while IL-1R was found in TNC neurons.
Conclusions:
- NLRP3 inflammasome activation in microglia within the TNC plays a crucial role in CM pathogenesis.
- The NLRP3 inflammasome mediates microglial-neuronal signaling involved in the inflammatory response.
- Targeting microglial NLRP3 activation offers a potential therapeutic strategy for managing chronic migraine by reducing central sensitization.
Related Concept Videos
01:13Induced-fit Model
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
02:16Measures of Central Tendency
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:39Receptor-mediated Endocytosis
01:23Binet's Contribution to Measures of Intelligence
01:25The Central Dogma